Skip to main content
Top
Published in: Clinical Rheumatology 12/2018

01-12-2018 | Original Article

Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis and meta-regression

Authors: Qingqing Liu, Jin Yang, Hairong He, Yong Yu, Jun Lyu

Published in: Clinical Rheumatology | Issue 12/2018

Login to get access

Abstract

This study aimed to explore whether interleukin-10 polymorphisms are associated with susceptibility to rheumatoid arthritis (RA). Studies that have analyzed the associations of the interleukin-10-1082G>A, -592C>A, and -819C>T polymorphisms with RA were searched for in PubMed and EMBASE. Sensitivity and cumulative analyses were conducted to measure the robustness of our findings. Egger’s linear regression and Begg’s funnel plots were performed to analyze publication bias. The source of heterogeneity was analyzed by subgroup analysis and meta-regression. This meta-analysis involved 2661 RA patients and 3249 controls in 16 studies. There were significant associations with RA in the AG vs AA model (OR = 0.79, 95% CI = 0.67–0.93, P < 0.01) and the AG + GG vs AA model (OR = 0.80, 95% CI = 0.69–0.93, P < 0.01) for the interleukin-10-1082G>A polymorphism, in the TC vs TT model (OR = 0.61, 95% CI = 0.44–0.84, P < 0.01) and the CC vs TT model (OR = 0.64, 95% CI = 0.46–0.89, P < 0.01) for the interleukin-10-819C>T polymorphism, and in the AC vs AA model (OR = 0.73, 95% CI = 0.56–0.96, P = 0.03) and the AC + CC vs AA model (OR = 0.68, 95% CI = 0.47–0.98, P = 0.04) for the interleukin-10-592C>A polymorphism. Meta-regression revealed that the genotyping method was a major cause of heterogeneity in the AC vs AA model and the AC + CC vs AA model for the interleukin-10-592C>A polymorphism. This meta-analysis showed the interleukin-10-1082G>A, -592C>A, and -819C>T polymorphisms are correlated with the susceptibility to RA. Meta-regression indicated that the genotyping method is a major driver of heterogeneity in the relationship between the interleukin-10-592C>A polymorphism and RA.
Appendix
Available only for authorised users
Literature
1.
go back to reference Picerno V, Ferro F, Adinolfi A, Valentini E, Tani C, Alunno A (2015) One year in review: the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 33:551–558PubMed Picerno V, Ferro F, Adinolfi A, Valentini E, Tani C, Alunno A (2015) One year in review: the pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 33:551–558PubMed
2.
go back to reference Weyand CM, Goronzy JJ (1997) The molecular basis of rheumatoid arthritis. J Mol Med 75:772–785CrossRef Weyand CM, Goronzy JJ (1997) The molecular basis of rheumatoid arthritis. J Mol Med 75:772–785CrossRef
3.
go back to reference Grutz G (2005) New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 77:3–15CrossRef Grutz G (2005) New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 77:3–15CrossRef
4.
go back to reference Tian G, Li JL, Wang DG, Zhou D (2014) Targeting IL-10 in auto-immune diseases. Cell Biochem Biophys 70:37–49CrossRef Tian G, Li JL, Wang DG, Zhou D (2014) Targeting IL-10 in auto-immune diseases. Cell Biochem Biophys 70:37–49CrossRef
5.
go back to reference Trifunovic J, Miller L, Debeljak Z, Horvat V (2015) Pathologic patterns of interleukin 10 expression--a review. Biochem Med (Zagreb) 25:36–48CrossRef Trifunovic J, Miller L, Debeljak Z, Horvat V (2015) Pathologic patterns of interleukin 10 expression--a review. Biochem Med (Zagreb) 25:36–48CrossRef
6.
go back to reference Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and interleukin-10 receptor. Annu Rev Immunol 19:683–765CrossRef Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and interleukin-10 receptor. Annu Rev Immunol 19:683–765CrossRef
7.
go back to reference Hernández-Bello J, Oregón-Romero E, Vázquez-Villamar M, García-Arellano S, Valle Y, Padilla-Gutiérrez JR, Román-Fernández IV, Palafox-Sánchez CA, Martínez-Bonilla GE, Muñoz-Valle JF (2017) Aberrant expression of interleukin-10 in rheumatoid arthritis: relationship with IL10 haplotypes and autoantibodies. Cytokine 95:88–96CrossRef Hernández-Bello J, Oregón-Romero E, Vázquez-Villamar M, García-Arellano S, Valle Y, Padilla-Gutiérrez JR, Román-Fernández IV, Palafox-Sánchez CA, Martínez-Bonilla GE, Muñoz-Valle JF (2017) Aberrant expression of interleukin-10 in rheumatoid arthritis: relationship with IL10 haplotypes and autoantibodies. Cytokine 95:88–96CrossRef
8.
go back to reference Manolova I, Miteva L, Ivanova M, Vasilev G, Stanilova S (2015) Polymorphisms in TNFA and IL10 gene promoters and risk of rheumatoid arthritis in Bulgarian population. Trakia Journal of Sciences 13:16–20CrossRef Manolova I, Miteva L, Ivanova M, Vasilev G, Stanilova S (2015) Polymorphisms in TNFA and IL10 gene promoters and risk of rheumatoid arthritis in Bulgarian population. Trakia Journal of Sciences 13:16–20CrossRef
9.
go back to reference Lagha A, Zidi S, Stayoussef M, Gazouani E, Kochkar R, Kochbati S, Almawi WY, Yacoubi-Loueslati B (2015) Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis. Pathol Biol 63:179–184CrossRef Lagha A, Zidi S, Stayoussef M, Gazouani E, Kochkar R, Kochbati S, Almawi WY, Yacoubi-Loueslati B (2015) Interleukin-1β, Interleukin1-Ra, Interleukin-10, and tumor necrosis factor-α polymorphisms in Tunisian patients with rheumatoid arthritis. Pathol Biol 63:179–184CrossRef
10.
go back to reference Ge L, Huang Y, Zhang H, Liu R, Xu N (2015) Association between polymorphisms of interleukin 10 with inflammatory biomarkers in east Chinese Han patients with rheumatoid arthritis. Joint Bone Spine 82:182–186CrossRef Ge L, Huang Y, Zhang H, Liu R, Xu N (2015) Association between polymorphisms of interleukin 10 with inflammatory biomarkers in east Chinese Han patients with rheumatoid arthritis. Joint Bone Spine 82:182–186CrossRef
11.
go back to reference Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012) Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep 39:81–87CrossRef Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2012) Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mol Biol Rep 39:81–87CrossRef
12.
go back to reference Ying B, Shi Y, Pan X, Song X, Huang Z, Niu Q, Cai B, Wang L (2011) Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis. Mol Biol Rep 38:379–385CrossRef Ying B, Shi Y, Pan X, Song X, Huang Z, Niu Q, Cai B, Wang L (2011) Association of polymorphisms in the human IL-10 and IL-18 genes with rheumatoid arthritis. Mol Biol Rep 38:379–385CrossRef
13.
go back to reference Paradowska-Gorycka A, Trefler J, Maciejewska-Stelmach J, Łacki JK (2010) Interleukin-10 gene promoter polymorphism in polish rheumatoid arthritis patients. Int J Immunogenet 37:225–231CrossRef Paradowska-Gorycka A, Trefler J, Maciejewska-Stelmach J, Łacki JK (2010) Interleukin-10 gene promoter polymorphism in polish rheumatoid arthritis patients. Int J Immunogenet 37:225–231CrossRef
14.
go back to reference Gambhir D, Lawrence A, Aggarwal A, Misra R, Mandal SK, Naik S (2010) Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in north Indian population. Rheumatol Int 30:1211–1217CrossRef Gambhir D, Lawrence A, Aggarwal A, Misra R, Mandal SK, Naik S (2010) Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in north Indian population. Rheumatol Int 30:1211–1217CrossRef
15.
go back to reference Trajkov D, Mishevska-Perchinkova S, Karadzova-Stojanoska A, Petlichkovski A, Strezova A, Spiroski M (2009) Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic Macedonians. Clin Rheumatol 28:1291–1300CrossRef Trajkov D, Mishevska-Perchinkova S, Karadzova-Stojanoska A, Petlichkovski A, Strezova A, Spiroski M (2009) Association of 22 cytokine gene polymorphisms with rheumatoid arthritis in population of ethnic Macedonians. Clin Rheumatol 28:1291–1300CrossRef
16.
go back to reference Nemec P, Pavkova-Goldbergova M, Gatterova J, Fojtik Z, Vasku A, Soucek M (2009) Association of the −1082 G/a promoter polymorphism of interleukin-10 gene with the autoantibodies production in patients with rheumatoid arthritis. Clin Rheumatol 28:899–905CrossRef Nemec P, Pavkova-Goldbergova M, Gatterova J, Fojtik Z, Vasku A, Soucek M (2009) Association of the −1082 G/a promoter polymorphism of interleukin-10 gene with the autoantibodies production in patients with rheumatoid arthritis. Clin Rheumatol 28:899–905CrossRef
17.
go back to reference Menegatti E, Davit A, Francica S, Berardi D, Rossi D, Baldovino S, Tovo PA, Sena LM, Roccatello D (2009) Genetic factors associated with rheumatoid arthritis and systemic vasculitis: evaluation of a panel of polymorphisms. Dis Markers 27:217–223CrossRef Menegatti E, Davit A, Francica S, Berardi D, Rossi D, Baldovino S, Tovo PA, Sena LM, Roccatello D (2009) Genetic factors associated with rheumatoid arthritis and systemic vasculitis: evaluation of a panel of polymorphisms. Dis Markers 27:217–223CrossRef
18.
go back to reference Ates O, Hatemi G, Hamuryudan V, Topal-Sarikaya A (2008) Tumor necrosis factor-alpha and Interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin Rheumatol 27:1243–1248CrossRef Ates O, Hatemi G, Hamuryudan V, Topal-Sarikaya A (2008) Tumor necrosis factor-alpha and Interleukin-10 gene promoter polymorphisms in Turkish rheumatoid arthritis patients. Clin Rheumatol 27:1243–1248CrossRef
19.
go back to reference Moreno OM, González CI, Saaibi DL, Otero W, Badillo R, Martín J, Ramírez G (2007) Polymorphisms of IL-10 gene promoter and rheumatoid arthritis in a Colombian population. Biomedica 27:56–65CrossRef Moreno OM, González CI, Saaibi DL, Otero W, Badillo R, Martín J, Ramírez G (2007) Polymorphisms of IL-10 gene promoter and rheumatoid arthritis in a Colombian population. Biomedica 27:56–65CrossRef
20.
go back to reference Hee CS, Gun SC, Naidu R, Gupta E, Somnath SD, Radhakrishnan AK (2007) Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Mod Rheumatol 17:429–435CrossRef Hee CS, Gun SC, Naidu R, Gupta E, Somnath SD, Radhakrishnan AK (2007) Comparison of single nucleotide polymorphisms in the human interleukin-10 gene promoter between rheumatoid arthritis patients and normal subjects in Malaysia. Mod Rheumatol 17:429–435CrossRef
21.
go back to reference Pawlik A, Kurzawski M, Szklarz BG, Herczynska M, Drozdzik M (2005) Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. Clin Rheumatol 24:480–484CrossRef Pawlik A, Kurzawski M, Szklarz BG, Herczynska M, Drozdzik M (2005) Interleukin-10 promoter polymorphism in patients with rheumatoid arthritis. Clin Rheumatol 24:480–484CrossRef
22.
go back to reference Padyukov L, Hytönen AM, Smolnikova M, Hahn-Zoric M, Nilsson N, Hanson LÅ, Tarkowski A, Klareskog L (2004) Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol 31:422–425PubMed Padyukov L, Hytönen AM, Smolnikova M, Hahn-Zoric M, Nilsson N, Hanson LÅ, Tarkowski A, Klareskog L (2004) Polymorphism in promoter region of IL10 gene is associated with rheumatoid arthritis in women. J Rheumatol 31:422–425PubMed
23.
go back to reference Niu YM, Du XY, Cai HX, Zhang C, Yuan RX, Zeng XT, Luo J (2015) Increased risks between Interleukin-10 gene polymorphisms and haplotype and head and neck cancer: a meta-analysis. Sci Rep 5:17149CrossRef Niu YM, Du XY, Cai HX, Zhang C, Yuan RX, Zeng XT, Luo J (2015) Increased risks between Interleukin-10 gene polymorphisms and haplotype and head and neck cancer: a meta-analysis. Sci Rep 5:17149CrossRef
24.
go back to reference Kantor R, Kim A, Thyssen JP, Silverberg JI (2016) Association of atopic dermatitis with smoking: a systematic review and meta-analysis. J Am Acad Dermatol 75:1119–1125.e1CrossRef Kantor R, Kim A, Thyssen JP, Silverberg JI (2016) Association of atopic dermatitis with smoking: a systematic review and meta-analysis. J Am Acad Dermatol 75:1119–1125.e1CrossRef
25.
go back to reference Ciccacci C, Conigliaro P, Perricone C, Rufini S, Triggianese P, Politi C, Novelli G, Perricone R, Borgiani P (2016) Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis. Clin Exp Immunol 186:157–163CrossRef Ciccacci C, Conigliaro P, Perricone C, Rufini S, Triggianese P, Politi C, Novelli G, Perricone R, Borgiani P (2016) Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis. Clin Exp Immunol 186:157–163CrossRef
26.
go back to reference Calabresi E, Petrelli F, Bonifacio AF, Puxeddu I, Alunno A (2018) One year in review 2018: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 36:175–184PubMed Calabresi E, Petrelli F, Bonifacio AF, Puxeddu I, Alunno A (2018) One year in review 2018: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol 36:175–184PubMed
27.
go back to reference Sundstrom B, Johansson I, Rantapaa-Dahlqvist S (2015) Diet and alcohol as risk factors for rheumatoid arthritis: a nested case-control study. Rheumatol Int 35:533–539CrossRef Sundstrom B, Johansson I, Rantapaa-Dahlqvist S (2015) Diet and alcohol as risk factors for rheumatoid arthritis: a nested case-control study. Rheumatol Int 35:533–539CrossRef
Metadata
Title
Associations between interleukin-10 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis and meta-regression
Authors
Qingqing Liu
Jin Yang
Hairong He
Yong Yu
Jun Lyu
Publication date
01-12-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 12/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4329-2

Other articles of this Issue 12/2018

Clinical Rheumatology 12/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.